AlveoliX

🌟 Exciting News! 🌟Do you like fashion? Do you love Milano? Well guess what! AlveoliX will be participating in the most fashionable Organs-on-a-Chip congress in Europe! And yes in Milano! At the European Organ-on-Chip Society EUROoCS 2024 (July 3rd-5th). Come to Discover with Laurène Froment and Daniel. A. Gutierrez our latest designs and capabilities to tackle the most challenging industry needs in Gut and Lung health. ✨We will be unveiling 2 developments in Lung/Gut-on-Chip. Poster 145: A breathing lung-on-chip for inhalation toxicology and safety assessment Poster 146: Advancing Drug Testing with a novel human 3D peristaltic Gut-on-Chip platform   🤝 Ready for a demo of our system? We would be thrilled to show you more live! 🔬 Visit our Booth Number 1 in Hall 2. 💬 Daniel and Laurène are your go-to persons: [email protected] / [email protected] Let’s talk! #OrganOnAChip #DrugDevelopment #ToxicologyStudies #translationalresearch #gutresearch #gut #Ulcerativecolitis #Lungresearch

Starting with hour 1️⃣ with a team at The Francis Crick Institute working towards treatments that will eradicate tuberculosis #WellcomeLeap Learn more: https://lnkd.in/eA37MRiD

Great participation from the industry at this year's EUROoCS in Milano! We had the pleasure to present AlveoliX and interact with the Organs-on-a-Chip expert community. Don't miss Laurène Froment and Daniel. A. Gutierrez poster session where Lung / Gut-on-a-Chip will be discussed in detail!

Great participation from the industry at this year's EUROoCS in Milano! We had the pleasure to present AlveoliX and interact with the Organs-on-a-Chip expert community. Don't miss Laurène Froment and Daniel. A. Gutierrez poster session where Lung / Gut-on-a-Chip will be discussed in detail!

🔔 Don't forget to register to Science & Dialogue panel discussion 2: Harmonization of NAMs — Can it really be global ? The session will take place this Thursday June 27 from 1-2:15 pm CET We have the privilege to welcome Dr Nicole Kleinstreuer from NICEATM Director at National Institute of Environmental Health Sciences (NIEHS), Dr Nina Hobi, CEO at AlveoliX and Dr Surat Saravanan, PhD, Senior Strategist at Humane Society International India. We are delighted to moderate the session with Prof Merel Ritskes-Hoitinga, from the Transitie Proefdiervrije Innovatie, and Utrecht University - Faculty of Humanities. We will explore and discuss current challenges, opportunities, and ongoing actions in favor of harmonizing NAMs, to ensure it can and will be regulated / accepted worldwide, and under the same criteria. Join us and register here → https://lnkd.in/e-7QyBN5 #NAMs #Discussion #Harmonization #Global

Organ-On-Chip Market worth $631,073 thousand by 2029 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐏𝐃𝐅 𝐁𝐫𝐨𝐜𝐡𝐮𝐫𝐞:-https://lnkd.in/dhFQG5GF Organ-on-Chip Market Size, Share & Trends by Organ Type (#Liver, #Kidney, #Intestine, #Lung, #Heart), Products (Instruments, Consumable, Software), Services (Standard, Custom), Model Type, Application (Toxicology, Drug Discovery, Stem Cell), Purpose & Region - Global Forecast to 2029. 𝐓𝐨𝐩 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬 Emulate, Inc. CN BIO INNOVATIONS LIMITED TissUse GmbH Hesperos Inc., MIMETAS Nortis Farmaceutica, InSphero Kirkstall Ltd. AxoSim Technologies Organovo Holdings, Inc. BiomimX® Srl SynVivo, Inc. Elveflow Microfluidics | an Elvesys brand AlveoliX

🙌 Thank you, Arunima Sengupta, Ph.D. #AleXis for your comprehensive summary and the insights from 𝓸𝓾𝓽𝓼𝓲𝓭𝓮 𝓽𝓱𝓮 𝓑𝓸𝔁 😉 Looks nice in #Nice. Enjoy the last part of the #conference, Happy Friday everyone!

🌍 𝗟𝗜𝗩𝗲𝟮𝟬𝟮𝟰 𝗶𝘀 𝗹𝗶𝘃𝗲, 𝗯𝗿𝗶𝗻𝗴𝗶𝗻𝗴 𝘁𝗼𝗴𝗲𝘁𝗵𝗲𝗿 𝗲𝘅𝗽𝗲𝗿𝘁𝘀 𝗶𝗻 𝗶𝗻-𝘃𝗶𝘁𝗿𝗼 𝗿𝗲𝘀𝗽𝗶𝗿𝗮𝘁𝗼𝗿𝘆 𝗿𝗲𝘀𝗲𝗮𝗿𝗰𝗵! 🌱𝗚𝗶𝘂𝗹𝗶𝗮 𝗥𝗮𝗴𝗴𝗶 𝗶𝘀 𝗹𝗶𝘃𝗲 𝗼𝗻 𝘀𝘁𝗮𝗴𝗲 𝘁𝗼𝗱𝗮𝘆 𝗮𝗻𝗱 𝗵𝗮𝗽𝗽𝘆 𝘁𝗼 𝗰𝗼𝗻𝗻𝗲𝗰𝘁 𝘄𝗶𝘁𝗵 𝗼𝘁𝗵𝗲𝗿 𝗲𝘅𝗽𝗲𝗿𝘁𝘀 𝗶𝗻 𝘁𝗵𝗲 𝗳𝗶𝗲𝗹𝗱.   Giulia: “We are very proud that Prof. Dr. Claus-Michael Lehr from Helmholtz Institute for Pharmaceutical Research Saarland demonstrated how AlveoliX 's breathing lung-on-chip technology, combined with Vitrocell Systems GmbH technology, can be effectively applied for inhalable drug testing.”    Curious to hear more about Giulia’s research? Here we go: “𝗔 𝗽𝗮𝘁𝗶𝗲𝗻𝘁-𝗱𝗲𝗿𝗶𝘃𝗲𝗱 𝗹𝘂𝗻𝗴-𝗼𝗻-𝗰𝗵𝗶𝗽 𝘁𝗼 𝗿𝗲𝗰𝗮𝗽𝗶𝘁𝘂𝗹𝗮𝘁𝗲 𝗜𝗻𝘁𝗲𝗿𝗹𝗲𝘂𝗸𝗶𝗻-𝟮 𝗶𝗻𝗱𝘂𝗰𝗲𝗱 𝘃𝗮𝘀𝗰𝘂𝗹𝗮𝗿 𝗹𝗲𝗮𝗸 𝘀𝘆𝗻𝗱𝗿𝗼𝗺𝗲.”   LIVe2024 is a unique platform for scientists and stakeholders from #academia, pharma, biotech, chemical, tobacco, consumer goods, medical devices industries, CROs, and regulatory agencies. Our focus is on predictive in vitro lung models for basic research and efficacy/toxicity testing. -Advances in basic research   -Innovations in efficacy and toxicity testing  -Regulatory and industry applications We’re excited to be part of LIVe2024 and look forward to connecting, learning, and innovating together! 🚀    #RespiratoryResearch #InVitroModels #LIVe2024 #ScienceInnovation #Biotech #Pharma #Academia    Arunima Sengupta, Ph.D. Epithelix Otmar Schmid Prof. Doris Wilfingseder Medizinische Universität Innsbruck Josue Sznitman Technion - Israel Institute of Technology Nuria Roldan Barbara Rothen-Rutishauser Samuel Constant Yuki Yamamoto Linda Steinacher Roche

After an inspiring and insightful week in Seattle at the MPS World Summit, we're back in Switzerland! A special shoutout to Lea Lara de Maddalena and Giulia Raggi, who perfectly represented us at the summit. 👏🙌 AlveoliX 's Operations Managers & Scientific Project Leads conclude: "It's exciting and motivating to see the rising interest in MPS and NAMs! We are already looking forward to the next MPS World Summit 2024 in Brussels!" Thank you to all our peers, including Vitrocell Systems GmbH, for the support and collaboration! 🤝✨ 𝗜𝘀 𝗮𝗻𝘆𝗼𝗻𝗲 𝘄𝗼𝗻𝗱𝗲𝗿𝗶𝗻𝗴 𝘄𝗵𝗮𝘁 𝗠𝗣𝗦 𝗺𝗲𝗮𝗻𝘀? Microphysiological systems (MPS) are a #bioengineering breakthrough, replicating organ architecture and function in vitro. Fueled by stem-cell technologies, a variety of human models and test systems are emerging, making experimental tools widely available through international and multidisciplinary #collaborations. 🌟🧬 The MPS World Summit is essential in forming a #community, accelerating scientific developments, and fostering global harmonization. This series presents the latest achievements, discusses advances and challenges, and facilitates communication between young scientists and field pioneers. 🌐🔬 Proud to be part of this vibrant community! Paul Schumacher 𝐓𝐨𝐛𝐢𝐚𝐬 𝐊𝐫𝐞𝐛𝐬